1 Clinically important upper GI bleeding |
3 |
237 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.63 [0.18, 2.22] |
1.1 Omeprazole vs placebo |
1 |
147 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.04 [0.07, 16.34] |
1.2 Omeprazole vs no prophylaxis |
1 |
80 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.74 [0.13, 4.18] |
1.3 Pantoprazole vs placebo |
1 |
10 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.28 [0.02, 4.66] |
2 Nosocomial pneumonia |
2 |
227 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.24 [0.77, 1.98] |
2.1 Omeprazole vs placebo |
1 |
147 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.67 [0.57, 4.86] |
2.2 Omeprazole vs no prophylaxis |
1 |
80 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.11 [0.66, 1.84] |
3 All‐cause mortality in ICU |
3 |
258 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.09 [0.60, 1.99] |
3.1 Omeprazole vs placebo |
2 |
178 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.20 [0.51, 2.83] |
3.2 Omeprazole vs no prophylaxis |
1 |
80 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.98 [0.42, 2.29] |
4 All‐cause mortality in hospital |
1 |
150 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.08 [0.54, 2.13] |
4.1 Omeprazole vs placebo |
1 |
150 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.08 [0.54, 2.13] |
5 Duration of ICU stay |
2 |
227 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.03 [‐1.63, 1.58] |
5.1 Omeprazole vs placebo |
1 |
147 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.90 [‐3.96, 2.16] |
5.2 Omeprazole vs no prophylaxis |
1 |
80 |
Mean Difference (IV, Fixed, 95% CI) |
0.30 [‐1.58, 2.18] |
6 Duration of intubation |
2 |
227 |
Mean Difference (IV, Fixed, 95% CI) |
0.36 [‐1.43, 2.15] |
6.1 Omeprazole vs placebo |
1 |
147 |
Mean Difference (IV, Fixed, 95% CI) |
0.5 [‐2.72, 3.72] |
6.2 Omeprazole vs no prophylaxis |
1 |
80 |
Mean Difference (IV, Fixed, 95% CI) |
0.30 [‐1.85, 2.45] |